28 Mar 2022 , 11:52 AM
Suven Life Sciences announced that the Board of Directors of the company at its meeting held on 28 March 2022 has approved the allotment of 1.81 crore equity shares on conversion of equivalent number of convertible warrants. Consequently, the paid up equity share capital has increased to 145382478 equity shares of Re 1 each.
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.